# 04_QA_REPORT.md

# Quality Assurance Report

## Identity

| Field | Value |
|---|---|
| QA Report ID | QA-PP-0227 |
| PP ID | PP-0227 |
| Title | Palliative Care |
| Version | 1.0.0 |
| Status | PASS — GOLD |
| QA Mode | Four-layer substantive QA |
| Source-First | PASS |
| Locked Decision Integrity | PASS |

---

# Executive QA Decision

# PASS — GOLD

PP-0227 is consistent with the approved and locked Decision Batch.

The package preserves:

- atomic palliative-care ownership;
- longitudinal palliative-care framing;
- patient/family-centered education;
- coexistence with active anticancer therapy;
- goals-of-care architecture;
- advance care planning;
- end-of-life interface;
- hospice distinction;
- PP-0228 boundary;
- evidence traceability;
- Knowledge Graph relationships;
- Gold artifact structure and depth.

No material blocker identified.

---

# Layer 1 — Content QA

## 1. Scope Compliance

### Required scope

PP-0227 must explain:

- what palliative care is;
- when it can be integrated;
- what goals it serves;
- how it relates to active cancer treatment;
- how it supports patients/families;
- how it interfaces with end-of-life care.

### Assessment

**PASS**

All required domains are represented.

---

## 2. Atomicity

### Test

Does PP-0227 answer one clinical educational question?

### Assessment

**PASS**

The package is specifically about the palliative-care framework.

It does not become:

- a metastatic gastric cancer package;
- a recurrent cancer package;
- a palliative systemic-treatment package;
- a best-supportive-care intervention manual;
- a hospice administrative manual.

---

## 3. Completeness

The CKO includes:

- metadata;
- objectives;
- scope;
- clinical blocks;
- patient explanation;
- misconceptions;
- key messages;
- patient questions;
- safety;
- evidence maturity;
- Knowledge Graph;
- boundary;
- revision history.

### Assessment

**PASS**

---

## 4. Internal Consistency

The following principles remain consistent across all artifacts:

- palliative care is longitudinal;
- palliative care can coexist with active treatment;
- palliative care is not hospice;
- stopping cancer treatment does not stop care;
- PP-0228 owns detailed supportive interventions;
- individualized prognosis/treatment decisions are excluded.

### Assessment

**PASS**

---

# Layer 2 — Clinical QA

## 5. Primary Guideline Alignment

### Source

NCCN Gastric Cancer v2.2026.

### Verified concepts

- prevention/relief of suffering;
- quality of life;
- patients and families;
- regardless of disease stage;
- regardless of other therapies;
- multimodality interdisciplinary approach;
- symptom-relieving interventions.

### Assessment

**PASS**

---

## 6. ESMO-ASCO Alignment

Verified concepts include:

- supportive needs from diagnosis;
- treatment;
- survivorship/rehabilitation;
- end of life;
- individual symptom assessment;
- psychosocial care;
- patient/caregiver involvement;
- multidisciplinary care;
- early palliative integration;
- advance care planning;
- goals of life/goals of care;
- family support;
- continuity;
- end-of-life care.

### Assessment

**PASS**

---

## 7. ACS Patient-Facing Alignment

The package correctly preserves:

- continued palliative/supportive care even when treatment stops;
- quality-of-life framing;
- hospice as an end-of-life context;
- family support.

### Assessment

**PASS**

---

## 8. NCI PDQ Alignment

The package correctly uses NCI PDQ for:

- palliative treatment context;
- systemic-treatment interface;
- local/procedural palliation.

It does not use NCI PDQ to expand PP-0227 into a systemic-treatment package.

### Assessment

**PASS**

---

## 9. No Unsafe Treatment Advice

The package does not prescribe:

- medication;
- dose;
- procedure;
- treatment cessation;
- hospice admission;
- individualized care pathway.

### Assessment

**PASS**

---

## 10. Prognosis Safety

The package explains prognosis conceptually but does not provide:

- survival estimates;
- prognostic calculator;
- individualized timeline.

### Assessment

**PASS**

---

## 11. Hospice Safety

Hospice is described conceptually.

No universal legal or insurance eligibility rule is asserted.

### Assessment

**PASS**

---

## 12. End-of-Life Safety

The package recognizes end-of-life care without turning PP-0227 into a terminal pharmacology protocol.

### Assessment

**PASS**

---

# Layer 3 — Educational QA

## 13. Patient-Facing Clarity

The package explicitly explains:

- what palliative care is;
- what it is not;
- why it can occur during treatment;
- why care continues if treatment stops;
- how goals can change.

### Assessment

**PASS**

---

## 14. Terminology

Technical concepts are explained:

- palliative care;
- best supportive care;
- goals of care;
- advance care planning;
- hospice;
- prognosis;
- multidisciplinary care.

### Assessment

**PASS**

---

## 15. Misconception Control

The package addresses:

- palliative care = giving up;
- palliative care = terminal care;
- palliative care = stopping chemotherapy;
- stopping treatment = stopping care;
- hospice = palliative care;
- palliative care = pain medication;
- palliative care = no active treatment;
- one universal palliative pathway.

### Assessment

**PASS**

---

## 16. Logical Flow

The CKO follows:

**Definition**

→ **Timing**

→ **Trajectory**

→ **Quality of life**

→ **Needs**

→ **Goals**

→ **Shared decisions**

→ **Advance planning**

→ **End of life**

→ **Hospice**

→ **Patient interpretation**

This is appropriate for a patient-facing educational node.

### Assessment

**PASS**

---

# Layer 4 — Governance QA

## 17. Source-First Audit

PP-specific source materials were searched before production.

Primary clinical evidence was anchored to:

- NCCN Gastric Cancer v2.2026;
- ESMO-ASCO 2023;
- ACS Stomach Cancer;
- NCI PDQ Gastric Cancer Treatment.

### Assessment

**PASS**

---

## 18. Gold Template Adherence

The four required artifacts are present:

- CKO;
- Knowledge Passport;
- Primary Evidence Package;
- QA Report.

The artifacts preserve:

- full Gold structure;
- patient-facing depth;
- evidence traceability;
- Knowledge Graph;
- clinical reasoning;
- QA depth;
- scope and boundary documentation.

### Assessment

**PASS**

---

## 19. Gold Depth Integrity

### Rule

Gold depth is a minimum standard.

The package must not be:

- compacted;
- shortened;
- summarized;
- reduced in evidence detail;
- reduced in QA depth;
- reduced in Knowledge Graph depth;
- reduced in patient-facing explanation.

### Assessment

**PASS**

The CKO provides extensive educational and patient-facing coverage.

The Knowledge Passport provides detailed runtime, classification, knowledge-unit, governance and boundary treatment.

The Evidence Package provides detailed source hierarchy, evidence matrix, appraisal, claims, limitations, gaps, translation, traceability and overlap verification.

The QA Report provides substantive four-layer review plus dedicated safety, overlap, evidence, numerical, Knowledge Graph, Gold-depth and package-integrity audits.

---

# Clinical Safety Review

## Safety Rule 1 — No automatic treatment cessation

**PASS**

## Safety Rule 2 — No individualized prognosis

**PASS**

## Safety Rule 3 — No hospice eligibility determination

**PASS**

## Safety Rule 4 — No medication dosing

**PASS**

## Safety Rule 5 — No detailed terminal-care protocol

**PASS**

## Safety Rule 6 — No universal referral threshold

**PASS**

## Safety Rule 7 — No symptom-management algorithm

**PASS**

---

# Patient Misconception Review

| Misconception | Corrective content | Status |
|---|---|---|
| Palliative care means giving up | Explicit myth/fact | PASS |
| Palliative care is only terminal care | Explicit myth/fact | PASS |
| Palliative care means stopping chemotherapy | Explicit myth/fact | PASS |
| Stopping treatment means stopping care | Explicit myth/fact | PASS |
| Hospice equals palliative care | Explicit myth/fact | PASS |
| Palliative care is only pain management | Explicit myth/fact | PASS |
| Palliative care means no active treatment | Explicit myth/fact | PASS |
| One pathway fits every patient | Explicit myth/fact | PASS |
| Palliative procedures mean cancer treatment failed | Explicit myth/fact | PASS |
| Goals are decided only by clinicians | Explicit myth/fact | PASS |

---

# Adjacent PP Overlap Audit

## PP-0208 — Palliative Systemic Therapy

### PP-0208 ownership

Palliative anticancer systemic therapy.

### PP-0227 ownership

Palliative-care framework.

### Result

**PASS — no substantive duplication.**

---

## PP-0222 — Management of Recurrent Gastric Cancer

### PP-0222 ownership

Recurrent disease management.

### PP-0227 ownership

Palliative needs in recurrence.

### Result

**PASS**

---

## PP-0223 — Metastatic Gastric Cancer

### PP-0223 ownership

Metastatic disease framework.

### PP-0227 ownership

Palliative-care framework.

### Result

**PASS**

---

## PP-0226 — HIPEC

### PP-0226 ownership

HIPEC treatment modality.

### PP-0227 ownership

Palliative-care principles and treatment-burden/goals context.

### Result

**PASS**

---

## PP-0228 — Best Supportive Care

### PP-0228 ownership

Detailed supportive interventions and symptom management.

### PP-0227 ownership

Palliative-care philosophy, timing, goals, integration and patient/family framework.

### Result

# **PASS — PRIMARY BOUNDARY VERIFIED**

---

## PP-0231 — Treatment-related Toxicity and Supportive Care

### PP-0231 ownership

Detailed treatment toxicity.

### PP-0227 ownership

High-level treatment-burden recognition and palliative framework.

### Result

**PASS**

---

## PP-0232 — Multidisciplinary Management

### PP-0232 ownership

Operational MDT framework.

### PP-0227 ownership

Interdisciplinary palliative-care principle.

### Result

**PASS**

---

# Evidence Traceability Audit

| Major Claim | Source Traceability | Status |
|---|---|---|
| Palliative-care goal | NCCN v2.2026 | PASS |
| Quality of life | NCCN v2.2026 | PASS |
| Patients/families | NCCN v2.2026 | PASS |
| Multidisciplinary approach | NCCN + ESMO-ASCO | PASS |
| Longitudinal trajectory | ESMO-ASCO | PASS |
| Early integration | ESMO-ASCO | PASS |
| Symptom assessment | ESMO-ASCO | PASS |
| Psychosocial needs | ESMO-ASCO | PASS |
| Advance care planning | ESMO-ASCO | PASS |
| Goals of care | ESMO-ASCO | PASS |
| End-of-life framework | ESMO-ASCO | PASS |
| Continuity/non-abandonment | ESMO-ASCO | PASS |
| Care after treatment cessation | ACS | PASS |
| Hospice interface | ACS | PASS |
| Palliative treatment interface | NCI PDQ + NCCN | PASS |

---

# Numerical Evidence Audit

PP-0227 intentionally contains no individualized numerical clinical thresholds or survival estimates.

### Assessment

**PASS**

This prevents false precision in a framework package whose core evidence is conceptual and care-process oriented.

---

# Knowledge Graph Audit

## Prerequisites

Present:

- PP-0222;
- PP-0223;
- PP-0208;
- relevant disease/treatment packages.

## Related

Present:

- PP-0226;
- PP-0228;
- PP-0231;
- PP-0232;
- nutrition;
- rehabilitation;
- psychosocial;
- end-of-life.

## Downstream

Present:

- PP-0228;
- PP-0231;
- symptom-specific supportive packages;
- survivorship/long-term follow-up where relevant.

### Assessment

**PASS**

---

# Gold Depth Integrity Review

## CKO

Contains:

- detailed objectives;
- scope;
- clinical blocks;
- patient explanation;
- misconceptions;
- key messages;
- patient questions;
- safety;
- evidence maturity;
- Knowledge Graph;
- boundary.

**PASS**

## Knowledge Passport

Contains:

- identity;
- classification;
- domain;
- journey;
- runtime;
- retrieval;
- scope;
- knowledge units;
- evidence classification;
- sources;
- governance;
- graph;
- boundary map;
- safety;
- version/change history.

**PASS**

## Evidence Package

Contains:

- clinical question;
- intent;
- scope;
- primary/supporting sources;
- evidence hierarchy;
- evidence matrix;
- detailed appraisal;
- claims;
- consistency;
- limitations;
- gaps;
- translation;
- traceability;
- boundary verification;
- Knowledge Graph;
- update triggers.

**PASS**

## QA Report

Contains substantive:

- content QA;
- clinical QA;
- educational QA;
- governance QA;
- safety;
- misconception;
- overlap;
- evidence;
- numerical;
- graph;
- depth;
- package integrity.

**PASS**

---

# Source-First Audit

### Primary source files searched

1. NCCN Gastric Cancer v2.2026.
2. ESMO-ASCO Recommendations 2023.
3. ACS Stomach Cancer.
4. ACS Immunotherapy for Stomach Cancer.
5. NCI Gastric Cancer Treatment PDQ.
6. PP Registry.
7. CORE_WORKING_RULES v1.7.
8. FREEZE GOLD POPULATION PACKAGE SPECIFICATION v1.1.
9. PP Discussion depth and format example.

### Assessment

**PASS**

---

# Locked Decision Integrity

## Locked PP scope

PP-0227 is the:

> **Palliative Care framework package**

with the primary architecture:

**Palliative Care framework**

versus

**Best Supportive Care detailed interventions.**

### Production assessment

No material scope reopening or architecture drift detected.

### Assessment

**PASS**

---

# Cross-Artifact Consistency

| Dimension | CKO | KP | EP | QA |
|---|---|---|---|---|
| Palliative-care framework | PASS | PASS | PASS | PASS |
| Longitudinal scope | PASS | PASS | PASS | PASS |
| Concurrent anticancer treatment | PASS | PASS | PASS | PASS |
| Goals of care | PASS | PASS | PASS | PASS |
| Advance care planning | PASS | PASS | PASS | PASS |
| End-of-life interface | PASS | PASS | PASS | PASS |
| Hospice distinction | PASS | PASS | PASS | PASS |
| PP-0228 boundary | PASS | PASS | PASS | PASS |
| Safety boundary | PASS | PASS | PASS | PASS |
| Knowledge Graph | PASS | PASS | PASS | PASS |

### Overall

**PASS**

---

# Boundary Integrity Audit

## Core

Palliative-care framework.

**PASS**

## Supporting

Necessary disease/treatment context without substantive ownership duplication.

**PASS**

## Explicitly Excluded

Detailed supportive/treatment procedures and individualized decisions.

**PASS**

## Delegated-to PP

Adjacent package ownership is explicit.

**PASS**

---

# Package Integrity

Expected:

```text
PP-0227_Palliative_Care_GOLD_v1.0.0/
├── 01_CKO.md
├── 02_KNOWLEDGE_PASSPORT.md
├── 03_PRIMARY_EVIDENCE_PACKAGE.md
└── 04_QA_REPORT.md
```

### Assessment

**PASS**

---

# Final QA Matrix

| QA Dimension | Status |
|---|---|
| Content QA | PASS |
| Clinical QA | PASS |
| Educational QA | PASS |
| Governance QA | PASS |
| Clinical Safety Review | PASS |
| Patient Misconception Review | PASS |
| Adjacent PP Overlap Audit | PASS |
| Evidence Traceability Audit | PASS |
| Numerical Evidence Audit | PASS |
| Knowledge Graph Audit | PASS |
| Gold Depth Integrity Review | PASS |
| Source-First Audit | PASS |
| Locked Decision Integrity | PASS |
| Cross-artifact Consistency | PASS |
| Boundary Integrity | PASS |
| Package Integrity | PASS |

---

# Final QA Status

# PASS — GOLD — READY FOR INTEGRATION

---

# Revision History

| Version | Date | Summary |
|---|---|---|
| 1.0.0 | 2026-08-09 | Initial Gold QA after approved PP-0227 Decision Batch |
